M. Elmansari et al., HYPERSENSITIVITY TO SEROTONIN AND ITS AGONISTS IN SEROTONIN-HYPERINNERVATED NEOSTRIATUM AFTER NEONATAL DOPAMINE DENERVATION, European journal of pharmacology, 261(1-2), 1994, pp. 171-178
Neonatal destruction of the nigrostriatal dopamine projection by intra
ventricular 6-hydroxydopamine leads to a serotonin (5-hydroxytryptamin
e, 5-HT) hyperinnervation of the adult neostriatum accompanied by incr
eased radioligand binding to 5-HT1B, 5-HT1nonAB and 5-HT2 receptors. T
he consequences of such 5-HT receptor changes on neuronal responsivene
ss to 5-HT and corresponding receptor agonists were assessed with a qu
antitative iontophoretic approach. For comparative purposes, similar d
ata were also obtained from rats 6-hydroxydopamine lesioned as adults,
showing severe neostriatal dopamine denervation but no 5-HT hyperinne
rvation. In controls, 5-HT and its receptor agonists, m-chlorophenylpi
perazine (mCPP; 5-HT1B/2C agonist) and dimethoxy-iodophenyl-aminopropa
ne (DOI; 5-HT2A/2C agonist), depressed the firing rate of a majority o
f the units tested. Three months after neonatal 6-hydroxydopamine lesi
on (5-HT-hyperinnervated tissue), inhibitory responses to all three ag
ents were significantly increased and comparable results were obtained
for 5-HT and DOI in the rostral versus caudal neostriatum. After 6-hy
droxydopamine lesion in adults, neither responsiveness to 5-HT, mCPP o
r DOI nor the density of 5-HT1B or 5-HT2A binding were significantly d
ifferent from control. Thus, the up-regulation of 5-HT1B, 5-HT2A and p
ossibly 5-HT2C receptors accompanying the 5-HT hyperinnervation after
neonatal but not after adult dopamine denervation was associated with
increased responsiveness (IT50) of neostriatal neurons to iontophorese
d 5-HT and its receptor agonists. Under these conditions, neostriatal
5-HT transmission might be enhanced in spite of a basal release seemin
gly comparable to normal (Jackson and Abercrombie, 1992, J. Neurochem.
58, 890). The elevated number of 5-HT2A receptors might also explain
why systemic treatment with 5-HT2A receptor antagonists reverses the s
pontaneous hyperactivity observed in these rats (Luthman et al., 1991,
J. Psychopharmacol. 5, 418).